June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Dexamethasone-induced robust upregulation of ArgBP2, an actin crosslinking, ZO-1 and focal adhesion interacting adaptor protein, in human trabecular meshwork cells.
Author Affiliations & Notes
  • Vasantha Rao
    Ophthalmology, Duke University School of Medicine, Durham, North Carolina, United States
    Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, North Carolina, United States
  • William Bachman
    Ophthalmology, Duke University School of Medicine, Durham, North Carolina, United States
  • Nikolai Skiba
    Ophthalmology, Duke University School of Medicine, Durham, North Carolina, United States
  • Ayon Chakraborty
    Ophthalmology, Duke University School of Medicine, Durham, North Carolina, United States
  • Camelia Eldawy
    Ophthalmology, Duke University School of Medicine, Durham, North Carolina, United States
  • Rupalatha Maddala
    Ophthalmology, Duke University School of Medicine, Durham, North Carolina, United States
  • Footnotes
    Commercial Relationships   Vasantha Rao, None; William Bachman, None; Nikolai Skiba, None; Ayon Chakraborty, None; Camelia Eldawy, None; Rupalatha Maddala, None
  • Footnotes
    Support  NIH grants- R01EY018590 and R01-EY028823.
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 478. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Vasantha Rao, William Bachman, Nikolai Skiba, Ayon Chakraborty, Camelia Eldawy, Rupalatha Maddala; Dexamethasone-induced robust upregulation of ArgBP2, an actin crosslinking, ZO-1 and focal adhesion interacting adaptor protein, in human trabecular meshwork cells.. Invest. Ophthalmol. Vis. Sci. 2021;62(8):478.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To understand the cytosolic and nuclear role(s) of actin cytoskeletal and cell adhesive proteins in trabecular meshwork (TM) cells in the context of aqueous humor outflow

Methods : Nuclear and cytosolic fractions isolated from primary cultures of human TM cells treated with dexamethasone for various lengths of time were subjected to quantitative proteomics analysis. The distribution and colocalization of AgrBP2 and its related c-Cbl associated protein (CAP/Ponsin) with actin cytoskeletal and focal adhesions proteins, and the dexamethasone-induced reorganization of these proteins in human TM cells were evaluated by immunofluorescence and immunoblotting analyses.

Results : Dexamethasone treatment (0.5 µM for 5-7 days) led to a significant increase in the levels of ArgBP2 (SORBS2) and CAP (SORBS1), which are the sorbin and SH3-domain containing, and flotillin interacting adaptor proteins, in both, the nuclear and cytosolic fractions of human TM cells. The increase in ArgBP2 levels was consistent in more than ten biological replicates of TM cells analyzed. While CAP exhibited a focal adhesion-specific distribution profile, ArgBP2 was found to colocalize with actin stress fibers and ZO-1, and distribute to the focal adhesions, lamellipodia, and nucleus. Upregulation of ArgBP2 and CAP in dexamethasone treated TM cells was associated with increased levels of chromatin remodelers including BRG1, MAT1 and MECP2. The Abl and Arg kinase inhibitor, dasatinib, was found to suppress dexamethasone-induced association of ArgBP2 and CAP with focal adhesions. Interestingly, the chromosomal localization of ArgBP2 at 4q35.1 is a recognized locus for an autosomal dominant POAG.

Conclusions : Taken together, ArgBP2 and its related cell adhesive proteins (CAP and Vinexin) appear to play a key role in dexamethasone-induced actin cytoskeletal crosslinking and cell adhesive interactions in TM cells, which are known to influence aqueous humor outflow and intraocular pressure.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×